Selection from HEOR Bibliography
| Search criteria | ||||
| Brazil |
||||
| A cross-sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update | ||||
| Mariana F Almas 1, Massoud Toussi 2, Elisa Valero 3, Annick Moureau 4, Lydie Marcelon | ||||
| 1IQVIA Real World Solutions, Porto Salvo, Portugal. 2IQVIA Real World &Analytics Solutions, La Défense, France. 3Global Pharmacovigilance, Sanofi Pasteur, Lyon, France. 4Global Biostatistical Sciences, Sanofi Pasteur, Marcy l'Etoile, France. 5Epidemiology and Benefit Risk, Global Pharmacovigilance, Sanofi Pasteur, Lyon, France. | ||||
| Pharmacoepidemiol Drug Saf . 2022 Jul;31(7):758-768. doi: 10.1002/pds.5447. Epub 2022 May 13 |
||||
| , Article | ||||
| , Brazil, Thailand | ||||
| Abstract: https://pubmed.ncbi.nlm.nih.gov/35505623/ | ||||
| Condition | Year | Language | Analysis type | |
| , Immunology and Vaccination, Risk Management & REMS | 2022 | English | , Clinical setting: Primary care, Epidemiological study, Survey research | |
| Cost analysis of sequencing new agents for the treatment of chronic lymphocytic leukemia from the perspective of the Brazilian supplementary health system | ||||
| Leandro Brust (1), Celso Arrais (2), Fabiano Pombo (3), Diego Kashiura (4), Pedro Vitor Pereira Lima (4), Ana Travassos (5), Rafael Silva (5), Straus Tanaka (5) | ||||
| 1: Dasa, Rio Grande do Sul, Brasil; 2: Universidade Federal de São Paulo, São Paulo, SP, Brasil; 3: Américas Centro de Oncologia Integrado, Rio de Janeiro, RJ, Brasil; 4: IQVIA Real World Insights Brazil, São Paulo, SP, Brasil; 5: AbbVie Brasil, São Paulo, SP, Brasil. | ||||
| J Bras Econ Saúde 2022;14(1):80-8 |
||||
| , Article | ||||
| , Brazil | ||||
| Abstract: https://jbes.com.br/wp-content/uploads/2022/05/JBES_141_80-88.pdf | ||||
| Condition | Year | Language | Analysis type | |
| , Health economics, Hematology | 2022 | Portuguese | , Cost effectiveness | |
| Direct costs associated with lupus nephritis management in the Private Healthcare System in Brazil: an expert panel perspective | ||||
| Danielle O. Silva (1), Nathalie David (1), Bruce Y. Kano (2), Diego Kashiura (2), Odirlei A. Monticielo (3), André Hayata (4), Mariana R. Gazzotti (1), Graziela Bernardino (1) | ||||
| 1: GSK, Rio de Janeiro, RJ, Brasil; 2: IQVIA Real World Insights, São Paulo, SP, Brazil; 3: Hospital de ClÃnicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; 4: Centro de Reumatologia Avançada, São Paulo, SP, Brazil | ||||
| J Bras Econ Saúde 2022;14(3):232-46 |
||||
| , Article | ||||
| , Brazil | ||||
| Abstract: https://jbes.com.br/wp-content/uploads/2022/12/JBES_143-p232-246.pdf | ||||
| Condition | Year | Language | Analysis type | |
| , Dermatology, Health economics | 2022 | English | , Cost analysis | |
| Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model | ||||
| Isabella Zuppo Laper (1), Cecilia Camacho-Hubner (2), Rafaela Vansan Ferreira (1), Claudenice Leite Bertoli de Souza (2), Marcus VinÃcius Simões (3), Fabio Fernandes (4), Edileide de Barros Correia (5), Ariane de Jesus Lopes de Abreu (1), Guilherme Silva Julian (2) | ||||
| 1: IQVIA Brazil; 2: Pfizer Brazil; 3: USP School of Medicine in Ribeirão Preto; 4: HC-FMU-SP; 5: Instituto Dante Pazzanese de Cardiologia | ||||
| PLoS One. 2024; 19(2): e0278738. |
||||
| , Article | ||||
| , Brazil | ||||
| Abstract: https://ncbi.nlm.nih.gov/pmc/articles/PMC10868784/ | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease | 2022 | English | ||
| Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults – A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study) | ||||
| Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas | ||||
| University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States | ||||
| , Article | ||||
| , Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA | ||||
| Abstract: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab491/6381446 | ||||
| Condition | Year | Language | Analysis type | |
| , Infectious disease | 2021 | English | , Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study | |
| Office-based Approach to Urinary Tract Infections in 50 000 Patients: Results From the REWIND Study | ||||
| Cai T, Palagin I, Brunelli R, Cipelli R, Pellini E, Truzzi JC, Van Bruwaene S | ||||
| Cai T: Department of Urology, Santa Chiara Regional Hospital, Trento, Italy. Cipelli: Obs Studies Consultat, IQVIA, RWS, Milan, Italy. | ||||
| , Article | ||||
| , Belgium, Brazil, Italy, Russian Federation | ||||
| Abstract: https://www.sciencedirect.com/science/article/pii/S0924857920301230?via%3Dihub | ||||
| Condition | Year | Language | Analysis type | |
| , Miscellaneous | 2021 | English | , clinical setting: Secondary care, Epidemiological study, Retrospective database analysis | |
| Trifluridine/tipiracil hydrochloride in the treatment of polytreated metastatic colorectal carcinoma: a cost-effectiveness analysis in the private payer perspective in Brazil | ||||
| Fernando Meton de Alencar Camara Vieira (1); Ana Paula Ornellas de Souza Victorino (1); Kelly Borges Araújo (1); Bianca Oesterreicher (2); Pedro Vitor Pereira Lima (2); Luciana Calvo Mardegan (3); Sandro Albuquerque (3); Juliana Simões Festa de Vasconcellos (3) | ||||
| 1: Instituto COI de Educação e Pesquisa, Rio de Janeiro, RJ, Brasil; 2: IQVIA Solutions, Real World Insights, São Paulo, SP, Brasil; 3: Laboratórios Servier, Rio de Janeiro, RJ, Brasil. | ||||
| , Article | ||||
| , Brazil | ||||
| Abstract: https://jbes.com.br/wp-content/uploads/2022/01/DOI_10_21115_JBES_v13_n3_p242-52.pdf | ||||
| Condition | Year | Language | Analysis type | |
| , Health economics, Oncology | 2021 | Portuguese | , Cost effectiveness | |
| Annualized Hospitalization Rate With Natalizumab vs Fingolimod in Second-Line Treatment for RRMS in the Public Healthcare System in Brazil: A Claim Database Approach | ||||
| Guilherme Silva Julian 1, Ricardo Papaléo Rosim 2, Estela Cristina Carneseca 3, Jéssica Rigolon 2 | ||||
| 1 IQVIA Brasil, São Paulo-SP, Brazil. 2 Biogen Brasil, São Paulo-SP, Brazil. 3 Proestat Consultoria EstatÃstica, Ribeirão Preto-SP, Brazil. | ||||
| PMID: 32119696 PMCID: PMC7051079 DOI: 10.1371/journal.pone.0229768 |
||||
| , Article | ||||
| , Brazil | ||||
| Abstract: https://pubmed.ncbi.nlm.nih.gov/32119696/ | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2020 | English | , Retrospective database analysis | |
| Cost of Macrovascular Complications in People With Diabetes From a Public Healthcare Perspective: A Retrospective Database Study in Brazil | ||||
| Guilherme Silva Julian 1, Daniel Campos 1, Julie Broe Honore 2, Flávia Sauer Tobaruella 3, Jung Hyun Yoon 3, Nino Hallén 2 | ||||
| 1 IQVIA Brasil, São Paulo, Brazil. 2 Novo Nordisk A/S, Søborg, Denmark. 3 Novo Nordisk Farmacêutica Do Brasil Ltda, São Paulo, Brazil. | ||||
| PMID: 32372710 DOI: 10.1080/13696998.2020.1764966 |
||||
| , Article | ||||
| , Brazil | ||||
| Abstract: https://www.tandfonline.com/doi/full/10.1080/13696998.2020.1764966 | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2020 | English | , Observational study, Retrospective database analysis | |
| Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data | ||||
| Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3 | ||||
| 1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ | ||||
| ESMO 2018 |
||||
| , Poster | ||||
| , Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2018 | English | ||
| Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD) | ||||
| Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3 | ||||
| IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ | ||||
| ESMO 2018 |
||||
| , Poster | ||||
| , Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2018 | English | ||
| Direct Costs of Type 2 Diabetes from fhe Brazilian Public Healthcare Sector Perspective | ||||
| Hnoosh A1, Babineaux SM2, Piras de Oliveira C3, McDonell A1, Vega-Hernandez G1 | ||||
| 1IMS, London, England, 2Eli Lilly & Company, Indianapolis, IN, USA, 3Eli Lilly do Brasil, Sao Paulo, Brazil | ||||
| ISPOR 4th Latin America Conference. Value in Health 2013 |
||||
| , Poster | ||||
| , Brazil | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2013 | English | , Burden of illness, Cost analysis, Cost of illness | |
| Direct Medical Management Costs of Diabetes-Related Complications in Brazil | ||||
| Vega-Hernández G1; Hnoosh A1; Jugrin A1; Todorova L2; Hansen BB3 | ||||
| 1 IMS Health, HEOR, London, UK; 2 Novo Nordisk International Operations, Zurich, Switzerland; 3 Novo Nordisk A/S, Soeborg, Denmark | ||||
| ISPOR 17th Annual International Meeting, June 2-6 2012, Washington, USA |
||||
| , Abstract | ||||
| , Brazil | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2012 | English | , Cost analysis | |